REGENERON PHARMACEUTICALS - COM

Historical Holders from Q1 2014 to Q1 2025

CUSIP
75886F907
Type / Class
Equity / COM
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
4.45K
Holdings value
$3.17M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
7
Number of sells
-1
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of REGENERON PHARMACEUTICALS - COM

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 4.45K $2.82M $634.23 3
2024 Q4 4.45K $3.17M -$413K $712.33 7
2024 Q3 5.03K $1.96M $0 $1,051.24 7
2024 Q2 $1,051.03 7
2024 Q1 $962.49 8
2023 Q4 $878.29 10
2023 Q3 $822.96 9
2023 Q2 0 $0 -$493K $718.54 8
2023 Q1 600 $493K +$493K $821.67 11
2022 Q4 $721.49 9
2022 Q3 $688.87 7
2022 Q2 $591.13 5
2022 Q1 $698.00 5
2021 Q4 $631.50 6
2021 Q3 $589.88 6
2021 Q2 $558.52 6
2021 Q1 $473.12 4
2020 Q4 $483.11 5
2020 Q3 $559.80 7
2020 Q2 $623.68 6
2020 Q1 $488.28 7
2019 Q4 0 $0 -$338K $375.51 0
2019 Q3 1.1K $338K +$338K $277.42 9
2019 Q2 $312.74 6
2019 Q1 $410.63 5
2018 Q4 $373.50 0
2018 Q3 $403.98 4
2018 Q2 $345.00 0
2018 Q1 $344.55 0
2017 Q4 $375.95 5
2017 Q3 $447.05 6
2017 Q2 $491.16 4
2017 Q1 $387.53 4
2016 Q4 $367.08 5
2016 Q3 $564.49 4
2016 Q2 $349.24 5
2016 Q1 $360.44 5
2015 Q4 0 $0 -$64K $542.87 6
2015 Q3 11.4K $64K +$64K $465.14 6
2015 Q2 $510.13 7
2015 Q1 $451.48 6
2014 Q4 $2,695.12 6
2014 Q3 $360.52 5
2014 Q2 $282.48 5
2014 Q1 $300.29 4